IDL Diagnostics AB (publ) (STO:IDLDX)

IDL Diagnostics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	35.31	36.57	47.79	50.72	65.19	18.4
Cash & Short-Term Investments	35.31	36.57	47.79	50.72	65.19	18.4
Cash Growth	-20.22%	-23.46%	-5.79%	-22.19%	254.25%	-56.25%
Accounts Receivable	8.87	10.83	10.32	6.08	7.12	2.72
Other Receivables	1.41	2.56	2.44	1.36	3.14	2.99
Receivables	10.27	13.39	12.75	7.44	10.25	5.7
Inventory	8.84	6.69	5.73	6.07	7.38	6.91
Prepaid Expenses	1.48	0.08	0.05	0.86	0.53	0.61
Other Current Assets	-	0	-0	0	0	0
Total Current Assets	55.9	56.73	66.31	65.1	83.35	31.63
Property, Plant & Equipment	13.57	14.9	17.42	2.74	3.32	1.16
Goodwill	98.99	98.99	98.99	98.99	138.57	178.15
Other Intangible Assets	6.52	0.57	0.85	1.24	0.31	0.51
Long-Term Deferred Charges	-	5.68	4.96	6.82	10.47	15.97
Other Long-Term Assets	0.05	-0	0	-	0	0
Total Assets	175.03	176.86	188.53	174.89	236.01	227.42

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.37	5.76	4.21	3.21	6.12	3.39
Accrued Expenses	8.57	7.2	7.62	5.34	4.32	3.68
Current Portion of Leases	2.27	2.2	2.06	-	-	-
Current Unearned Revenue	-	0.22	-	-	-	-
Other Current Liabilities	1.64	2.29	1.1	2.69	2.87	2.89
Total Current Liabilities	16.85	17.67	14.99	11.25	13.32	9.96
Long-Term Leases	9.89	11.04	13.24	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	0
Total Liabilities	26.74	28.71	28.22	11.25	13.32	9.96

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	23.04	23.04	23.04	23.04	23.04	11.46
Additional Paid-In Capital	441.01	441.01	441.01	441.01	440.76	376.73
Retained Earnings	-315.75	-315.89	-303.74	-300.4	-241.1	-174.67
Comprehensive Income & Other	-	-	0	-	0	0
Total Common Equity	148.29	148.16	160.31	163.65	222.69	213.52
Minority Interest	-	-	-	-	-	3.93
Shareholders' Equity	148.29	148.16	160.31	163.65	222.69	217.45
Total Liabilities & Equity	175.03	176.86	188.53	174.89	236.01	227.42

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.16	13.24	15.3	-	-	-
Net Cash (Debt)	23.16	23.34	32.49	50.72	65.19	18.4
Net Cash Growth	-47.68%	-28.17%	-35.95%	-22.19%	254.25%	-56.25%
Net Cash Per Share	0.10	0.10	0.14	0.22	0.30	0.20
Filing Date Shares Outstanding	230.36	230.36	230.36	230.36	230.36	114.61
Total Common Shares Outstanding	230.36	230.36	230.36	230.36	230.36	114.61
Working Capital	39.05	39.06	51.32	53.85	70.03	21.67
Book Value Per Share	0.64	0.64	0.70	0.71	0.97	1.86
Tangible Book Value	42.78	48.6	60.46	63.42	83.82	34.86
Tangible Book Value Per Share	0.19	0.21	0.26	0.28	0.36	0.30
Machinery	-	7.71	7.04	6.89	6.48	3.6

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error